References
- Coiffier B, Lepage E, Briere J, . CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346:235–242.
- Habermann TM, Weller EA, Morrison VA, . Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol 2006;24: 3121–3127.
- Bartlett NL, Petroni GR, Parker BA, . Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854. Cancer 2001;92: 207–217.
- Pfreundschuh M, Trumper L, Kloess M, . Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. Blood 2004;104:634–641.
- Grann VR, Hershman D, Jacobson JS, . Outcomes and diffusion of doxorubicin-based chemotherapy among elderly patients with aggressive non-Hodgkin lymphoma. Cancer 2006;107: 1530–1541.
- Link BK, Brooks J, Wright K, . Diffuse large B-cell lymphoma in the elderly: diffusion of treatment with rituximab and survival advances with and without anthracyclines. Leuk Lymphoma 2011; 52:994–1002.
- Huntington SF, Talbott MS, Greer JP, . Toxicities and outcomes among septuagenarians and octogenarians with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy. Leuk Lymphoma 2012;53: 1461–1468.
- Hasselblom S, Stenson M, Werlenius O, . Improved outcome for very elderly patients with diff use large B-cell lymphoma in the immunochemotherapy era. Leuk Lymphoma 2012;53:394–399.
- Kwak LW, Halpern J, Olshen RA, . Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis. J Clin Oncol 1990;8:963–977.
- Lepage E, Gisselbrecht C, Haioun C, . Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte). Ann Oncol 1993;4: 651–656.
- Mori M, Niitsu N, Takagi T, . Reduced-dose chop therapy for elderly patients with non-Hodgkin's lymphoma. Leuk Lymphoma 2001;41:359–366.
- Extermann M, Boler I, Reich RR, . Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer 2011 Nov 9. [Epub ahead of print]